Ignite Creation Date:
2025-12-25 @ 4:32 AM
Ignite Modification Date:
2026-04-24 @ 6:03 AM
Study NCT ID:
NCT05539118
Status:
NOT_YET_RECRUITING
Last Update Posted:
2022-09-14
First Post:
2022-08-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Interferon-α1b Combined With Toripalimab and Anlotinib Hydrochloride in Advanced Unresectable Melanoma
Sponsor:
Xijing Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
KY20222092-C-1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None